TP53 and P21 polymorphisms: Response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer

This publication has 38 references indexed in Scilit:

• The influence of HER2 genotypes as molecular markers in ovarian cancer outcome
  Biochemical and Biophysical Research Communications, 2005
• A genetic variant in the gene encoding the stress70 protein chaperone family member STCH is associated with gastric cancer in the Japanese population
  Biochemical and Biophysical Research Communications, 2005
• G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer
  Biochemical and Biophysical Research Communications, 2005
• Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in theTP53gene on survival in patients with advanced ovarian carcinoma
  Human Mutation, 2004
• p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer1
  Gynecologic Oncology, 2004
• Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women
  Gynecologic Oncology, 2004
• Metabolic susceptibility genes and prostate cancer risk in a southern European population: The role of glutathione S‐transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms
  The Prostate, 2003
• Genetic analysis of benign ovarian tumors
  International Journal of Cancer, 2003
• Mutant p53 protein expression interferes with p53-independent apoptotic pathways
  Oncogene, 1998
• Polymorphisms in P21CIP1/WAF1 are not correlated with TP53 status in sporadic ovarian tumours
  European Journal of Cancer, 1996